Pediatrix Medical Group (MD) Stock Looks Undervalued Despite Its 154% Run

Pediatrix Medical Group has delivered a strong share price run in recent years, and the question now is whether that move lines up with the cash the business can realistically generate. With the stock changing hands around US$29.55, investors are asking if the current valuation is fully supported by its underlying cash flows.

• Over the past 3 years Pediatrix Medical Group has returned 154.1%, which puts a lot of weight on whether its cash generation can support that kind of share price reset.

• The group relies on physician services and related healthcare operations, so long term value hinges on how efficiently it can convert those service revenues into steady, recurring cash flows after the cost of staffing and running its practices.

• What if you looked at Pediatrix Medical Group through its earnings instead? See what Pediatrix Medical Group's 13.4x P/E says about the price .

The stock's next move may depend on whether Pediatrix Medical Group's current price can be fully explained by the intrinsic value suggested by its cash flows.

To see how Pediatrix Medical Group's cash flow story compares with other opportunities built on recurring operations, line it up against a set of solid balance sheet and fundamentals stocks screener (26 results) .

Is Pediatrix Medical Group Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model here looks at the cash Pediatrix Medical Group can return to shareholders over time and discounts it back to today. On the latest twelve month numbers the group produced about $224.9 million in free cash flow, which is a meaningful pool of cash for a business with a share price of $29.55.

The projection set assumes Pediatrix Medical Group shifts to slightly lower free cash flow in the near term, then runs with relatively steady, slowly growing cash generation over the following decade. When those future cash flows are discounted back using this 2 Stage Free Cash Flow to Equity approach, the DCF calculation suggests an intrinsic value that sits substantially above where the stock trades today. That gap points to a market that is placing a cautious label on those projected cash flows relative to what the model implies they are worth. Find out what Pediatrix Medical Group could be worth using our Discounted Cash Flow (DCF) estimate .

The Pediatrix Medical Group Narrative: What Would Justify Today's Price?

Narratives for Pediatrix Medical Group pick up where the valuation puzzle leaves off and spell out which paths for future growth, margins and earnings would need to play out for the shares to look meaningfully mispriced against today's level, whether on the upside or the downside, on Simply Wall St's Community page. Each Narrative treats Pediatrix Medical Group's fair value as a thesis you can track over time, rather than a one off snapshot.